首页> 美国卫生研究院文献>Open Medicine >Our experience in the treatment of Malignant Fibrous Hystiocytoma of the larynx: clinical diagnosis therapeutic approach and review of literature
【2h】

Our experience in the treatment of Malignant Fibrous Hystiocytoma of the larynx: clinical diagnosis therapeutic approach and review of literature

机译:我们在喉恶性纤维性细胞增多症治疗中的经验:临床诊断治疗方法和文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hereditary spherocytosis (HS) and Chronic myelocytic leukemia (CML) are both life threatening hemotologic diseases. They are rarely seen to occur simultaneously in one individual patient. Here we demonstrate a case of HS associated with CML in this study. The patient is a young female, diagnosed with HS in 2005, and was given partial embolization of the splenic artery. She got significant remission after the procedure. In 2008, she was found abnormal in blood routine test, after bone marrow routine, chromosome and fusion gene tests, she was diagnosed with CML (chronic phase). She did not receive regular treatment until 3 months prior, and is currently being treated with Dasatimib. She achieved hematological remission, but had no significant improvement in chromosome and fusion gene figures. Due to her severe condition of hemolysis, a splenectomy or an allogeneic hematopoietic stem cell transplantation is considered.
机译:遗传性血球增多症(HS)和慢性粒细胞性白血病(CML)都是威胁生命的血液病。很少看到它们在单个患者中同时发生。在这里,我们演示了本研究中与CML相关的HS病例。该患者是一名年轻女性,于2005年被确诊为HS,并接受了脾动脉部分栓塞治疗。手术后她的病情明显减轻。 2008年,她在血液常规检查中发现异常,经过骨髓常规,染色体和融合基因检测后,被诊断为CML(慢性期)。她直到3个月前才接受常规治疗,目前正在接受Dasatimib的治疗。她实现了血液学缓解,但是染色体和融合基因的数字没有明显改善。由于她的严重溶血状况,因此考虑行脾切除术或异基因造血干细胞移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号